ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,059Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 1454

$927K Total Retail Price of All Prescriptions

Rank: 115 out of 1454

787 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 787 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 787 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 16,505 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 611 568 1 3
AMLODIPINE BESYLATE 610 561 2 2
SIMVASTATIN 516 474 3 1
METOPROLOL TARTRATE 446 423 4 10
METOPROLOL SUCCINATE 411 381 5 13
FUROSEMIDE 399 383 6 6
HYDROCODONE-ACETAMINOPHEN 399 340 S3 6 7
PRAVASTATIN SODIUM 381 348 8 12
ATENOLOL 373 305 9 18
LOSARTAN POTASSIUM 372 370 10 14
LEVOTHYROXINE SODIUM 361 311 11 5
GABAPENTIN 358 320 12 16
LISINOPRIL 303 283 13 4
METFORMIN HCL ER 295 266 14 41
LOVASTATIN 274 229 15 39
LOSARTAN-HYDROCHLOROTHIAZIDE 259 232 16 38
ZOLPIDEM TARTRATE 257 217 17 19
FLUOXETINE HCL 247 213 18 72
MIRTAZAPINE 219 219 19 53
POTASSIUM CHLORIDE 202 202 20 15
DONEPEZIL HCL 186 174 21 29
ATORVASTATIN CALCIUM 185 166 22 11
ALLOPURINOL 178 177 23 28
CRESTOR 177 168 24 22
SYNTHROID 176 172 25 25
TRIAMTERENE-HCTZ 170 144 26 44
COUMADIN 169 169 27 119
PREDNISONE 155 151 28 36
METFORMIN HCL 151 117 29 8
GLIMEPIRIDE 148 131 30 33
DIVALPROEX SODIUM 145 144 31 106
FENOFIBRATE 141 129 32 68
HYDROCHLOROTHIAZIDE 138 121 33 9
TAMSULOSIN HCL 136 125 34 34
WARFARIN SODIUM 135 128 35 17
FINASTERIDE 125 125 36 94
NAMENDA 123 123 37 48
SERTRALINE HCL 122 105 38 26
LANTUS 121 100 39 51
SPIRONOLACTONE 121 117 39 63
TRAZODONE HCL 118 96 41 50
BUPROPION HCL SR 117 100 42 207
ALENDRONATE SODIUM 116 104 43 35
POLYETHYLENE GLYCOL 3350 115 99 44 61
IPRATROPIUM BROMIDE 112 108 45 221
FLUTICASONE PROPIONATE 105 90 46 30
CITALOPRAM HBR 105 105 46 21
CARVEDILOL 104 101 48 24
TRAMADOL HCL 103 94 49 20
DIOVAN 100 94 50 40
DOXAZOSIN MESYLATE 100 93 50 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 79 52 27
DIOVAN HCT 93 75 53 75
PANTOPRAZOLE SODIUM 92 88 54 31
VERAPAMIL ER 91 83 55 89
AZITHROMYCIN 88 81 56 42
DILTIAZEM 24HR CD 83 83 57 76
MINOXIDIL 83 65 57 333
MELOXICAM 79 75 59 37
RANITIDINE HCL 79 78 59 43
DOXYCYCLINE HYCLATE 79 71 59 110
NORTRIPTYLINE HCL 78 73 62 257
ACTOS 77 69 63 90
DILTIAZEM 24HR ER 73 69 64 120
CYMBALTA 72 71 65 55
PROAIR HFA 72 55 65 56
CARBIDOPA-LEVODOPA 70 70 67 130
NEXIUM 69 51 68 23
LEVOXYL 69 68 68 84
METOCLOPRAMIDE HCL 66 62 70 121
CLOPIDOGREL 66 66 70 32
METHOCARBAMOL 66 65 R 70 210
LIPITOR 65 58 73 74
CALCITONIN-SALMON 63 63 74 325
ISOSORBIDE MONONITRATE ER 60 60 75 46
LACTULOSE 58 57 76 152
QUETIAPINE FUMARATE 57 49 77 91
LANTUS SOLOSTAR 55 51 78 79
GLIPIZIDE XL 54 39 79 85
KLOR-CON M20 54 51 79 54
CIPROFLOXACIN HCL 54 47 79 64
NITROGLYCERIN PATCH 52 50 82 190
ADVAIR DISKUS 52 52 82 47
EVISTA 51 27 84 136
NAPROXEN 50 48 85 122
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.